Entrada Therapeutics Ownership | Who Owns Entrada Therapeutics?
Entrada Therapeutics Ownership Summary
Entrada Therapeutics is owned by 23.20% institutional investors, 12.77% insiders, and 64.03% retail investors. Baker bros. advisors lp is the largest institutional shareholder, holding 11.98% of TRDA shares. US Small-Cap Growth II Equity Comp is the top mutual fund, with 4.86% of its assets in Entrada Therapeutics shares.
TRDA Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Entrada Therapeutics | 23.20% | 12.77% | 64.03% |
| Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
| Industry | Biotech Stocks | 68.48% | 9.65% | 21.87% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Baker bros. advisors lp | 4.87M | 11.98% | $84.13M |
| 5am venture management | 4.41M | 10.85% | $76.22M |
| Mpm asset management | 4.38M | 10.78% | $75.75M |
| Price t rowe associates inc /md/ | 2.90M | 7.15% | $50.19M |
| Janus henderson group | 2.08M | 5.12% | $36.01M |
| Blackrock | 1.69M | 5.06% | $24.14M |
| Blackrock funding, inc. /de | 1.97M | 4.86% | $34.14M |
| Vanguard group | 1.46M | 3.60% | $25.32M |
| Fmr | 1.40M | 3.45% | $24.20M |
| Wellington management group llp | 1.03M | 2.54% | $17.84M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Mpm asset management | 4.38M | 60.89% | $75.75M |
| 5am venture management | 4.41M | 18.19% | $76.22M |
| Stepstone group lp | 761.28K | 11.51% | $13.16M |
| Tcg crossover management | 584.96K | 0.99% | $10.11M |
| Baker bros. advisors lp | 4.87M | 0.90% | $84.13M |
| Nan fung group | 49.08K | 0.73% | $848.63K |
| Baybridge capital group | 28.56K | 0.36% | $493.86K |
| Virtus etf advisers | 3.92K | 0.03% | $67.85K |
| Moore capital management, lp | 105.00K | 0.02% | $1.82M |
| Pdt partners | 12.54K | 0.02% | $216.78K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Janus henderson group | 2.08M | 0.02% | 368.91K |
| Vanguard group | 1.46M | 0.00% | 241.05K |
| Blackrock | 1.69M | 0.00% | 207.70K |
| Goldman sachs group | 285.27K | 0.00% | 200.81K |
| Blackrock funding, inc. /de | 1.97M | 0.00% | 151.62K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Redmile group | - | - | -560.97K |
| Fmr | 1.40M | 0.00% | -343.58K |
| Price t rowe associates inc /md/ | 2.90M | 0.01% | -146.55K |
| Marshall wace, llp | - | - | -100.11K |
| Millennium management | 12.53K | 0.00% | -98.42K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Jacobs levy equity management | 134.24K | 0.01% | 134.24K | $1.91M |
| Mackenzie financial | 14.50K | 0.00% | 14.50K | $95.03K |
| Verition fund management | 14.03K | 0.00% | 14.03K | $242.58K |
| Susquehanna group, llp | 12.93K | - | 12.93K | $223.59K |
| Public employees retirement system of ohio | 8.60K | 0.00% | 8.60K | $122.55K |
Sold Out
| Holder | Change |
|---|---|
| Nelson, van denburg & campbell wealth management group | -4.00 |
| Parallel advisors | -16.00 |
| Advantage alpha capital partners lp | -20.00 |
| Srs capital advisors | -45.00 |
| Plato investment management | -61.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 62 | -38.61% | 9,425,072 | -68.69% | 23 | 0.42% | 37 | -43.08% | 13 | -27.78% |
| Sep 30, 2024 | 101 | 21.69% | 30,100,570 | 1.46% | 74 | 0.98% | 65 | 12.07% | 18 | 63.64% |
| Jun 30, 2024 | 82 | 7.89% | 29,668,719 | 13.99% | 88 | 1.43% | 58 | 61.11% | 11 | -52.17% |
| Mar 31, 2024 | 76 | 22.58% | 26,027,444 | -0.97% | 78 | 1.26% | 36 | 12.50% | 23 | 64.29% |
| Dec 31, 2023 | 62 | 12.73% | 26,281,950 | 0.95% | 78 | 1.28% | 32 | 39.13% | 14 | - |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| US Small-Cap Growth II Equity Comp | 1.82M | 4.86% | -124.82K |
| T. Rowe Price New Horizons | 1.71M | 4.54% | - |
| Vanguard Total Stock Mkt Idx Inv | 952.64K | 2.53% | - |
| iShares Russell 2000 ETF | 647.17K | 1.72% | -5.61K |
| Fidelity Growth Compy Commingled Pl S | 575.17K | 1.53% | 794.00 |
| Fidelity Growth Compy Commingled Pl O | 561.18K | 1.51% | - |
| T. Rowe Price New Horizons Tr-Z | 450.73K | 1.20% | 1.62K |
| T. Rowe Price New Horizons Tr-A | 450.73K | 1.20% | 1.62K |
| Fidelity Growth Company Fund | 349.03K | 0.93% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 342.91K | 0.91% | 7.05K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Mar 17, 2025 | WENTWORTH KORY JAMES | Chief Financial Officer | Sell | $19.04K |
| Dec 10, 2024 | MPM BIOVENTURES 2018, L.P. | - | Sell | $476.36K |
| Dec 11, 2024 | MPM BIOVENTURES 2018, L.P. | - | Sell | $440.75K |
| Dec 11, 2024 | MPM BioVentures 2014, L.P. | - | Sell | $440.75K |
| Dec 10, 2024 | MPM BioVentures 2014, L.P. | - | Sell | $476.36K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q1 | - | 1 |
| 2024 Q4 | - | 17 |
| 2024 Q3 | - | 13 |
| 2024 Q2 | 6 | 6 |
| 2024 Q1 | 7 | 4 |
TRDA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools